These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2665050)

  • 1. Review of the modes of action of colloidal bismuth subcitrate.
    Hall DW
    Scand J Gastroenterol Suppl; 1989; 157():3-6; discussion 21-2. PubMed ID: 2665050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric mucosa protection and prostaglandin E2 generation in rats by colloidal bismuth subcitrate (DE-NOL).
    Hall DW; van den Hoven WE
    Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):308-19. PubMed ID: 3473983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
    Wagstaff AJ; Benfield P; Monk JP
    Drugs; 1988 Aug; 36(2):132-57. PubMed ID: 3053124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mode of action of colloidal bismuth subcitrate.
    Lee SP
    Scand J Gastroenterol Suppl; 1991; 185():1-6. PubMed ID: 1957120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric mucosa protective effects of colloidal bismuth subcitrate (DE-NOL).
    Hall DW; van den Hoven WE
    Int J Tissue React; 1987; 9(5):427-32. PubMed ID: 3478321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colloidal bismuth subcitrate causes sustained release of gastric mucosal prostaglandin E2.
    Mertz-Nielsen A; Steenberg P; Neumark T; Bukhave K; Rask-Madsen J
    Aliment Pharmacol Ther; 1991 Apr; 5(2):127-33. PubMed ID: 1888815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor (EGF) in the gastroprotective and ulcer healing actions of colloidal bismuth subcitrate (De-Nol) in rats.
    Konturek SJ; Dembinski A; Warzecha Z; Bielanski W; Brzozowski T; Drozdowicz D
    Gut; 1988 Jul; 29(7):894-902. PubMed ID: 3260885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial action of bismuth in relation to Campylobacter pyloridis colonization and gastritis.
    Marshall BJ; Armstrong JA; Francis GJ; Nokes NT; Wee SH
    Digestion; 1987; 37 Suppl 2():16-30. PubMed ID: 3622946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the understanding of the mechanism of cytoprotective action by colloidal bismuth subcitrate.
    Konturek SJ; Radecki T; Piastucki I; Drozdowicz D
    Scand J Gastroenterol Suppl; 1986; 122():6-10. PubMed ID: 3465028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphologic evaluation of gastric mucosal protection by colloidal bismuth subcitrate (De-Nol).
    van den Hoven WE; Birtwhistle RD; Hall DW
    Int J Tissue React; 1988; 10(5):297-304. PubMed ID: 3250943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective properties of colloidal bismuth subcitrate on gastric mucosa.
    Hall DW; van den Hoven WE
    Scand J Gastroenterol Suppl; 1986; 122():11-3. PubMed ID: 3465026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
    Rösch W
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colloidal bismuth subcitrate-induced changes on gastric mucosal hemodynamics in the rat: gastric mucosal blood flow after CBS treatment.
    Eleftheriadis E; Kotzampassi K; Tzartinoglou E; Salem A; Aletras H
    Gastroenterol Jpn; 1991 Jun; 26(3):283-6. PubMed ID: 1889688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent experimental and clinical studies on the pharmacology of colloidal bismuth subcitrate.
    Elder JB
    Scand J Gastroenterol Suppl; 1986; 122():14-6. PubMed ID: 3535016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of colloidal bismuth subcitrate in gastric ulcer and gastritis.
    Tytgat GN; Rauws E; Langenberg W
    Scand J Gastroenterol Suppl; 1986; 122():22-9. PubMed ID: 3535018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical indications and efficacy of colloidal bismuth subcitrate.
    Lambert JR
    Scand J Gastroenterol Suppl; 1991; 185():13-21. PubMed ID: 1957121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colloidal bismuth subcitrate (De-Nol) inhibits degradation of gastric mucus by Campylobacter pylori protease.
    Sarosiek J; Bilski J; Murty VL; Slomiany A; Slomiany BL
    Am J Gastroenterol; 1989 May; 84(5):506-10. PubMed ID: 2470250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against chemically-induced oxidative gastrointestinal tissue injury in rats by bismuth salts.
    Bagchi D; Carryl OR; Tran MX; Bagchi M; Vuchetich PJ; Krohn RL; Ray SD; Mitra S; Stohs SJ
    Dig Dis Sci; 1997 Sep; 42(9):1890-900. PubMed ID: 9331152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the gastroprotective and ulcer-healing effects of colloidal bismuth subcitrate.
    Konturek SJ; Radecki T; Piastucki I; Drozdowicz D
    Digestion; 1987; 37 Suppl 2():8-15. PubMed ID: 3622948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colloidal bismuth subcitrate evokes adaptive cytoprotection in rat gastric mucosa.
    Balint GA
    Acta Med Hung; 1991; 48(3-4):197-201. PubMed ID: 1822857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.